Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late-window intravenous alteplase versus placebo for acute ischemic stroke with penumbral mismatch
ACTRN12610000011088Phase 3Completed
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Alteplase with Placebo (2 arms). Primary endpoint: Modified Rankin Scale score 0-1. Started Aug 2010; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ACTRN12610000011088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000011088.